Oral contraceptive use does not affect bone mass

November 27, 2000

Hershey, Pa. --- New research from Penn State College of Medicine shows that oral contraceptive pill (OCP) use by healthy teenage females does not affect their peak bone mass, or their growth.

Peak hip bone mineral density is achieved in late adolescence, usually by age 16. In this study, participants had their total body and hip bone density measured with using a DXA scanner. Bone density and bone mass was measured to see if there was any change caused by OCP use.

The study involved 62 white females who were studied from ages 12 to 20. There were 28 young women who used birth control pills for at least 6 months and were still using at age 20, with the average duration of use of 22 months; and 34 non-users. They are part of the Penn State Young Women's Health Study, which is a prospective epidemiological study that began in 1990 and believed to be the largest study of its kind.

Tom Lloyd, professor of health evaluation sciences and obstetrics and gynecology, said, "There was no difference in bone density between the two groups. This is good news because hormones in OCPs might, in theory, affect bone density, and peak bone mass is important in preventing osteoporosis later in life."

He notes that while there has been extensive research with older women on the use of OCPs and bone density, no previous studies have been conducted with teenaged women.

"We know that young women in particular are also very concerned about undesirable body changes," says Lloyd. "The average woman gains 40 to 50 percent of her skeletal mass - approximately 1,000 grams of bone mass during adolescence."
-end-
Lloyd, also director, Penn State Young Women's Health Study; Denise Taylor, clinical research coordinator; Hung Mo Lin, biostatistician and assistant professor of health evaluation sciences; Amy Matthews, biostatistical analyst; Douglas Eggil, associate professor of radiology; and Richard Legro, M.D., associate professor of obstetrics and gynecology, all Penn State College of Medicine, published their findings in "Oral Contraceptive Use by Teenage Women Does Not Affect Peak Bone Mass: A Longitudinal Study," is published in the October issue of the journal Fertility and Sterility.

Their work was sponsored by the National Institutes of Health through its support of the General Clinical Research Center at Penn State Milton S. Hershey Medical Center.

Penn State

Related Bone Density Articles from Brightsurf:

Romosozumab substantially builds bone density in hip and spine
New research presented at ACR Convergence, the American College Rheumatology's annual meeting, reveals that romosozumab, an osteoporosis drug, produces substantial gains in bone mineral density in the hip and lumbar spine within one year, and that transitioning patients to a potent antiresorptive drug can lead to even more bone density gains.

Bone density is associated with regular use, study finds
Researchers at the Beckman Institute at the University of Illinois Urbana-Champaign have found that bone density and frame size of women is associated with habitual use in tasks that involve domestic labor.

New guidelines for assessment of bone density and microarchitecture in vivo with HR-pQCT
There is an urgent need for guidance and consensus on the methods for, and reporting of, high-resolution peripheral quantitative computed tomography (HR-pQCT) imaging so that different studies can be compared to each other.

Adults with undiagnosed Celiac disease have lower bone density, says first study on topic
Research by George Mason University College of Health and Human Services found lower bone density in adults who are likely to have undiagnosed celiac disease, an autoimmune disease triggered by consuming gluten, despite this group consuming more calcium and phosphorous than the control group.

Family history of diabetes linked to increased bone mineral density
The association between type 2 diabetes and increased fracture risk is well documented.

Lower than expected risk of bone density decline with Truvada PrEP
Researchers have shown that among users of pre-exposure prophylaxis (PrEP) to prevent against AIDS that includes tenofovir (Truvada), those with daily use -- very high adherence -- had only about a 1% average decrease in bone mineral density in the spine and a 0.5% decline in the hip.

Sex-specific effects of DHEA on bone mineral density and body composition
Women 55 and older have an increased risk of bone and muscle loss but therapy with the hormone Dehydroepiandrosterone (DHEA) may help prevent bone loss and increase muscle mass in older women, according to a new study led by Catherine M.

Beyond bone mineral density: Additional bone traits predict risk for fracture
In the largest prospective study of its kind, researchers from Beth Israel Deaconess Medical Center (BIDMC) and the Institute for Aging Research at Hebrew SeniorLife used high-resolution tomography imaging to assess whether bone characteristics besides bone mineral density can predict risk of fracture.

A fracture anywhere reduces bone density everywhere
New studies from UC Davis Health are among the first to associate fractures with systemic bone loss.

More dairy associated with higher bone density and greater spine strength in men over 50
Researchers from Hebrew SeniorLife's Institute for Aging Research (IFAR), Wageningen University, Tilburg University, University of Reading, and Beth Israel Deaconess Medical Center (BIDMC) have discovered that higher intake of dairy foods, such as milk, yogurt, and cheese, is associated with higher volumetric bone mineral density and vertebral strength at the spine in men.

Read More: Bone Density News and Bone Density Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.